MimiVax
MimiVax is commercializing intellectual property developed at Roswell Park Cancer Institute (RPCI). Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€18—27m (Dealroom.co estimates Dec 2021.)
Buffalo New York (HQ)
Authorizing premium user...